May 15, 2017 / 11:59 AM / 3 months ago

BRIEF-Nuvo Pharmaceuticals announces district court decision to uphold U.S. Pennsaid 2% patent

May 15 (Reuters) - Nuvo Pharmaceuticals Inc

* Nuvo Pharmaceuticals announces district court decision to uphold U.S. Pennsaid 2% patent

* Court upheld validity of Horizon Pharma's U.S. patent covering Pennsaid 2%

* Pennsaid 2% has multiple orange book listed patents with terms that extend to 2030 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below